Search Results - "Ahuja, Vijaykamal"

In Vitro and In Vivo Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosis by SOLAPURE, Suresh, DINESH, Neela, PARAB, Manish, VISHWAS, K. G, KUMAR, Naveen, BALGANESH, Meenakshi, BALASUBRAMANIAN, V, SHANDIL, Radha, RAMACHANDRAN, Vasanthi, SHARMA, Sreevalli, BHATTACHARJEE, Deepa, GANGULY, Samit, REDDY, Jitendar, AHUJA, Vijaykamal, PANDUGA, Vijender

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Effect of repeated dosing on rifampin exposure in BALB/c mice by Hosagrahara, Vinayak, Reddy, Jitendar, Ganguly, Samit, Panduga, Vijender, Ahuja, Vijaykamal, Parab, Manish, Giridhar, Jayashree

“…The discovery of novel therapeutics for the treatment of tuberculosis involves routine testing in a mouse model over four weeks of daily dosing with test…”
Get full text

Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo by Shirude, Pravin S, Shandil, Radha, Sadler, Claire, Naik, Maruti, Hosagrahara, Vinayak, Hameed, Shahul, Shinde, Vikas, Bathula, Chandramohan, Humnabadkar, Vaishali, Kumar, Naveen, Reddy, Jitendar, Panduga, Vijender, Sharma, Sreevalli, Ambady, Anisha, Hegde, Naina, Whiteaker, James, McLaughlin, Robert E, Gardner, Humphrey, Madhavapeddi, Prashanti, Ramachandran, Vasanthi, Kaur, Parvinder, Narayan, Ashwini, Guptha, Supreeth, Awasthy, Disha, Narayan, Chandan, Mahadevaswamy, Jyothi, Vishwas, KG, Ahuja, Vijaykamal, Srivastava, Abhishek, Prabhakar, KR, Bharath, Sowmya, Kale, Ramesh, Ramaiah, Manjunatha, Choudhury, Nilanjana Roy, Sambandamurthy, Vasan K, Solapure, Suresh, Iyer, Pravin S, Narayanan, Shridhar, Chatterji, Monalisa

“…We report 1,4-azaindoles as a new inhibitor class that kills Mycobacterium tuberculosis in vitro and demonstrates efficacy in mouse tuberculosis models. The…”
Get full text

Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase B by Kale, Manoj G, Raichurkar, Anandkumar, P, Shahul Hameed, Waterson, David, McKinney, David, Manjunatha, M. R, Kranthi, Usha, Koushik, Krishna, Jena, Lalit kumar, Shinde, Vikas, Rudrapatna, Suresh, Barde, Shubhada, Humnabadkar, Vaishali, Madhavapeddi, Prashanti, Basavarajappa, Halesha, Ghosh, Anirban, Ramya, VK, Guptha, Supreeth, Sharma, Sreevalli, Vachaspati, Prakash, Kumar, K.N. Mahesh, Giridhar, Jayashree, Reddy, Jitendar, Panduga, Vijender, Ganguly, Samit, Ahuja, Vijaykamal, Gaonkar, Sheshagiri, Kumar, C. N. Naveen, Ogg, Derek, Tucker, Julie A, Boriack-Sjodin, P. Ann, de Sousa, Sunita M, Sambandamurthy, Vasan K, Ghorpade, Sandeep R

“…A pharmacophore-based search led to the identification of thiazolopyridine ureas as a novel scaffold with antitubercular activity acting through inhibition of…”
Get full text

Identification and Mitigation of a Reactive Metabolite Liability Associated with Aminoimidazoles by Srivastava, Abhishek, Ramachandran, Sreekanth, Hameed, Shahul P, Ahuja, VijayKamal, Hosagrahara, Vinayak P

“…Reactive metabolites (RMs) have been implicated as causal factors in many drug-associated idiosyncratic toxicities. This study aims at identification and…”
Get full text

Thiazolopyridone ureas as DNA gyrase B inhibitors: Optimization of antitubercular activity and efficacy by Kale, Ramesh R., Kale, Manoj G., Waterson, David, Raichurkar, Anandkumar, Hameed, Shahul P., Manjunatha, M.R., Kishore Reddy, B.K., Malolanarasimhan, Krishnan, Shinde, Vikas, Koushik, Krishna, Jena, Lalit Kumar, Menasinakai, Sreenivasaiah, Humnabadkar, Vaishali, Madhavapeddi, Prashanti, Basavarajappa, Halesha, Sharma, Sreevalli, Nandishaiah, Radha, Mahesh Kumar, K.N., Ganguly, Samit, Ahuja, Vijaykamal, Gaonkar, Sheshagiri, Naveen Kumar, C.N., Ogg, Derek, Boriack-Sjodin, P. Ann, Sambandamurthy, Vasan K., de Sousa, Sunita M., Ghorpade, Sandeep R.

“…Scaffold hopping from the thiazolopyridine ureas led to thiazolopyridone ureas with potent antitubercular activity acting through inhibition of DNA GyrB ATPase…”
Get full text